Home
/
MAXCYTE, INC.
/
Financials
/
Quarterly
MAXCYTE, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that MAXCYTE, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$6.83M
Nov 13, 2025
Q2
2025
Jun 30, 2025
$8.51M
Aug 6, 2025
Q1
2025
Mar 31, 2025
$10.39M
May 8, 2025
Q3
2025
Sep 30, 2024
$8.16M
Nov 13, 2025
Q2
2025
Jun 30, 2024
$10.43M
Aug 6, 2025
Q1
2025
Mar 31, 2024
$11.34M
May 8, 2025
Q3
2024
Sep 30, 2023
$8.00M
Nov 6, 2024
Q2
2024
Jun 30, 2023
$9.04M
Aug 6, 2024
Q1
2024
Mar 31, 2023
$8.58M
May 7, 2024
Q3
2023
Sep 30, 2022
$10.64M
Nov 8, 2023
Q2
2023
Jun 30, 2022
$9.61M
Aug 9, 2023
Q1
2023
Mar 31, 2022
$11.59M
May 10, 2023
Q3
2022
Sep 30, 2021
$10.14M
Nov 9, 2022
Q2
2022
Jun 30, 2021
$7.11M
Aug 10, 2022
Q1
2022
Mar 31, 2021
$6.49M
May 9, 2022
Q3
2021
Sep 30, 2020
$6.76M
Nov 10, 2021
Q2
2021
Jun 30, 2020
$5.15M
Sep 13, 2021
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$4.60M
Nov 13, 2025
Q2
2025
Jun 30, 2025
$5.82M
Aug 6, 2025
Q1
2025
Mar 31, 2025
$5.74M
May 8, 2025
Q3
2025
Sep 30, 2024
$5.61M
Nov 13, 2025
Q2
2025
Jun 30, 2024
$4.97M
Aug 6, 2025
Q1
2025
Mar 31, 2024
$5.58M
May 8, 2025
Q3
2024
Sep 30, 2023
$4.16M
Nov 6, 2024
Q2
2024
Jun 30, 2023
$5.62M
Aug 6, 2024
Q1
2024
Mar 31, 2023
$4.96M
May 7, 2024
Q3
2023
Sep 30, 2022
$7.15M
Nov 8, 2023
Q2
2023
Jun 30, 2022
$6.98M
Aug 9, 2023
Q1
2023
Mar 31, 2022
$6.86M
May 10, 2023
Q3
2022
Sep 30, 2021
$5.61M
Nov 9, 2022
Q2
2022
Jun 30, 2021
$4.22M
Aug 10, 2022
Q1
2022
Mar 31, 2021
$4.24M
May 9, 2022
Q3
2021
Sep 30, 2020
$4.67M
Nov 10, 2021
Q2
2021
Jun 30, 2020
$2.33M
Sep 13, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($12.42M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($12.36M)
Aug 6, 2025
Q3
2025
Jun 30, 2025
($12.36M)
Nov 13, 2025
Q1
2025
Mar 31, 2025
($10.26M)
May 8, 2025
Q2
2025
Mar 31, 2025
($10.26M)
Aug 6, 2025
Q3
2025
Mar 31, 2025
($10.26M)
Nov 13, 2025
Q3
2025
Sep 30, 2024
($11.56M)
Nov 13, 2025
Q3
2025
Jun 30, 2024
($9.38M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($9.38M)
Aug 6, 2025
Q3
2025
Mar 31, 2024
($9.53M)
Nov 13, 2025
Q2
2025
Mar 31, 2024
($9.53M)
Aug 6, 2025
Q1
2025
Mar 31, 2024
($9.53M)
May 8, 2025
Q3
2024
Sep 30, 2023
($11.25M)
Nov 6, 2024
Q3
2024
Jun 30, 2023
($10.51M)
Nov 6, 2024
Q2
2024
Jun 30, 2023
($10.51M)
Aug 6, 2024
Q2
2024
Mar 31, 2023
($10.88M)
Aug 6, 2024
Q1
2024
Mar 31, 2023
($10.88M)
May 7, 2024
Q3
2024
Mar 31, 2023
($10.88M)
Nov 6, 2024
Q3
2023
Sep 30, 2022
($6.43M)
Nov 8, 2023
Q3
2023
Jun 30, 2022
($8.26M)
Nov 8, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($14.15M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($14.23M)
Aug 6, 2025
Q1
2025
Mar 31, 2025
($12.30M)
May 8, 2025
Q3
2025
Sep 30, 2024
($14.05M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($11.97M)
Aug 6, 2025
Q1
2025
Mar 31, 2024
($12.28M)
May 8, 2025
Q3
2024
Sep 30, 2023
($13.95M)
Nov 6, 2024
Q2
2024
Jun 30, 2023
($13.07M)
Aug 6, 2024
Q1
2024
Mar 31, 2023
($13.18M)
May 7, 2024
Q3
2023
Sep 30, 2022
($7.71M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
($8.74M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
($4.16M)
May 10, 2023
Q3
2022
Sep 30, 2021
($2.44M)
Nov 9, 2022
Q2
2022
Jun 30, 2021
($4.42M)
Aug 10, 2022
Q1
2022
Mar 31, 2021
($6.37M)
May 9, 2022
Q3
2021
Sep 30, 2020
($2.84M)
Nov 10, 2021
Q2
2021
Jun 30, 2020
($2.84M)
Sep 13, 2021